Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Key Ratios

NASDAQLPCN
Price & Volume
Recent Price$4.08
52 Week High$11.79
52 Week Low$2.31
Average Volume (30 days)27.30K
Beta1.21
Share Related Items
Market Cap$21.82M
Shares Outstanding5.35M
Float5.02M
Dividend Information
Yield %--
Annual Dividend--
Payout Ratio-32.3%
Financial Strength
Quick Ratio (MRQ)13.4
Current Ratio (MRQ)13.6
LT Debt/Capital (MRQ)0%
Total Debt/Equity (MRQ)0%
Valuation Ratios
Price/Earnings (TTM)--
Price/Sales (TTM)4.37
Price/Book (MRQ)0.98
Price/Cash Flow (TTM)(2.10)
Per Share Data
Earnings (TTM)($1.84)
Sales (TTM)$1.42
Book Value (MRQ)$3.99
Cash Flow (TTM)($0.88)
Cash (MRQ)$4.22
Management Effectiveness
Return on Equity (TTM)-34.0%
Return on Assets (TTM)-31.7%
Return on Investment (TTM)-26.1%
Profitability
Gross Margin (TTM)152.4%
EBIT Margin (TTM)-135.5%
Profit Margin (TTM)-176.8%